[HTML][HTML] Insulin-like growth factor receptor signaling in tumorigenesis and drug resistance: a challenge for cancer therapy
H Hua, Q Kong, J Yin, J Zhang, Y Jiang - Journal of hematology & …, 2020 - Springer
Insulin-like growth factors (IGFs) play important roles in mammalian growth, development,
aging, and diseases. Aberrant IGFs signaling may lead to malignant transformation and …
aging, and diseases. Aberrant IGFs signaling may lead to malignant transformation and …
[HTML][HTML] HER3 in cancer: from the bench to the bedside
L Gandullo-Sánchez, A Ocaña, A Pandiella - Journal of Experimental & …, 2022 - Springer
The HER3 protein, that belongs to the ErbB/HER receptor tyrosine kinase (RTK) family, is
expressed in several types of tumors. That fact, together with the role of HER3 in promoting …
expressed in several types of tumors. That fact, together with the role of HER3 in promoting …
[HTML][HTML] Role of drug catabolism, modulation of oncogenic signaling and tumor microenvironment in microbe-mediated pancreatic cancer chemoresistance
M Capula, M Perán, G Xu, V Donati, D Yee… - Drug Resistance …, 2022 - Elsevier
Pancreatic ductal adenocarcinoma (PDAC) has one of the highest incidence/death ratios
among all neoplasms due to its late diagnosis and dominant chemoresistance. Most PDAC …
among all neoplasms due to its late diagnosis and dominant chemoresistance. Most PDAC …
Costs and causes of oncology drug attrition with the example of insulin-like growth factor-1 receptor inhibitors
V Jentzsch, L Osipenko, JW Scannell… - JAMA Network …, 2023 - jamanetwork.com
Importance The development of oncology drugs is expensive and beset by a high attrition
rate. Analysis of the costs and causes of translational failure may help to reduce attrition and …
rate. Analysis of the costs and causes of translational failure may help to reduce attrition and …
[HTML][HTML] Gemcitabine resistance of pancreatic cancer cells is mediated by IGF1R dependent upregulation of CD44 expression and isoform switching
C Chen, S Zhao, X Zhao, L Cao, A Karnad… - Cell Death & …, 2022 - nature.com
Chemoresistance in pancreatic cancer cells may be caused by the expansion of inherently
resistant cancer cells or by the adaptive plasticity of initially sensitive cancer cells. We …
resistant cancer cells or by the adaptive plasticity of initially sensitive cancer cells. We …
[HTML][HTML] Tumor microenvironment and metabolic remodeling in gemcitabine‐based chemoresistance of pancreatic cancer
Z Gu, Y Du, X Zhao, C Wang - Cancer Letters, 2021 - Elsevier
Pancreatic ductal adenocarcinoma (PDAC) is a solid malignant tumor with a very low
operative rate and a poor patient prognosis. Therefore, gemcitabine (GEM)-based …
operative rate and a poor patient prognosis. Therefore, gemcitabine (GEM)-based …
[HTML][HTML] New insights into the role of adipocytes in pancreatic cancer progression: paving the way towards novel therapeutic targets
Pancreatic cancer (PC) remains one of the most lethal malignancies across the world, which
is due to delayed diagnosis and resistance to current therapies. The interactions between …
is due to delayed diagnosis and resistance to current therapies. The interactions between …
The RTK interactome: overview and perspective on RTK heterointeractions
MD Paul, K Hristova - Chemical reviews, 2018 - ACS Publications
Receptor tyrosine kinases (RTKs) play important roles in cell growth, motility, differentiation,
and survival. These single-pass membrane proteins are grouped into subfamilies based on …
and survival. These single-pass membrane proteins are grouped into subfamilies based on …
[HTML][HTML] Curcumin and berberine co-loaded liposomes for anti-hepatocellular carcinoma therapy by blocking the cross-talk between hepatic stellate cells and tumor …
J Wu, C Qi, H Wang, Q Wang, J Sun, J Dong… - Frontiers in …, 2022 - frontiersin.org
Cancer-associated fibroblasts (CAFs) are a major component of the tumor microenvironment
(TME). In hepatocellular carcinoma (HCC), quiescent hepatic stellate cells (HSCs) could be …
(TME). In hepatocellular carcinoma (HCC), quiescent hepatic stellate cells (HSCs) could be …
[HTML][HTML] Drugging IGF-1R in cancer: New insights and emerging opportunities
P Wang, VCY Mak, LWT Cheung - Genes & diseases, 2023 - Elsevier
The insulin-like growth factor (IGF) axis plays important roles in cancer development and
metastasis. The type 1 IGF receptor (IGF-1R) is a key member in the IGF axis and has long …
metastasis. The type 1 IGF receptor (IGF-1R) is a key member in the IGF axis and has long …